A novel NOD-derived murine model of primary Sjogren's syndrome

Arthritis and Rheumatism

Volumn 41, Issue 1, 1998, Pages 150-156

  Robinson, Christopher P ^a   Yamachika, Shigeo ^a   Bounous, Denise I ^b   Brayer, Jason ^a   Jonsson, Roland ^c   Holmdahl, Rikard ^d   Peck, Ammon B ^a   Humphreys Beher, Michael G ^a  

^a UNIVERSITY OF FLORIDA   (United States)

^b UNIVERSITY OF GEORGIA   (United States)

^c UNIVERSITY OF BERGEN   (Norway)

^d LUND UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINUCLEAR ANTIBODY; CYSTEINE PROTEINASE; MAJOR HISTOCOMPATIBILITY ANTIGEN; SECRETORY PROTEIN;

ANIMAL MODEL; ARTICLE; AUTOIMMUNE DISEASE; CELL LYSATE; EXOCRINE GLAND; FEMALE; GENETIC SUSCEPTIBILITY; INSULITIS; LACRIMAL FLUID; LACRIMAL GLAND; LYMPHOCYTIC INFILTRATION; MAJOR HISTOCOMPATIBILITY COMPLEX; MALE; MOUSE; NONHUMAN; PANCREAS; PRIORITY JOURNAL; SALIVA; SALIVARY GLAND; SJOEGREN SYNDROME;

ANIMALS; DIABETES MELLITUS, TYPE 1; DISEASE MODELS, ANIMAL; GENE EXPRESSION; HISTOCOMPATIBILITY ANTIGENS CLASS I; LACRIMAL APPARATUS; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, INBRED NOD; MUTAGENESIS; SJOGREN'S SYNDROME; SUBMANDIBULAR GLAND; THYROID GLAND;

EID: 0031982570     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/1529-0131(199801)41:1<150::AID-ART18>3.0.CO;2-T     Document Type: Article

References (30)

1. Fox RI, Kang H-I. Pathogenesis of Sjögren's syndrome. Rheum Dis Clin North Am 1992;18:517-38.
2. Fox P, Speight P. Current concepts of autoimmune exocrinopathy: immunologic mechanisms in the salivary pathology of Sjögren's syndrome. Crit Rev Oral Biol Med 1996;7:144-58.
3. Jonsson R, Mountz J. Experimental models of Sjögren's syndrome. In: Bona C, Siminovitch KA, Zanetti M, Theofilopoulos AN, editors. The molecular pathology of autoimmune diseases. New York: Harwood Acad.; 1993. p. 333-45.
4. Skarstein K, Wahren M, Zaura E, Hattori M, Jonsson R. Characterization of the T cell receptor repertoire and anti-Ro/SSA autoantibodies in relation to sialadenitis in NOD mice. Autoimmunity 1995;22:9-16.
5. Nishimori I, Bratanova T, Toshkov I, Caffrey T, Mogaki M, Shibata Y, et al. Induction of experimental autoimmune sialoadenitis by immunization of PL/J mice with carbonic anhydrase II. J Immunol 1995;154:4865-73.
6. Hu Y, Nakagawa Y, Purushotham KR, Humphreys-Beher MG. Functional changes in the salivary glands of autoimmune disease-prone NOD mice. Am J Physiol 1992;263:E607-14.
7. Humphreys-Beher MG, Hu Y, Nakagawa Y, Wang PL. Purushotham KR. Utilization of the NOD mouse as a model for the study of secondary Sjögren's syndrome. Adv Exp Med Biol 1994;350:631-6.
8. Humphreys-Beher MG, Brinkley L, Purushotham KR, Wang P-L, Nakagawa Y, Dusek D, et al. Characterization of antinuclear autoantibodies present in the serum from nonobese diabetic mice. Clin Immunol Immunopathol 1993;68:350-6.
9. Robinson C, Yamamoto H, Peck A, Humphreys-Beher MG. Genetically programmed development of salivary gland abnormalities in the NOD mouse: a potential trigger for sialoadenitis of NOD mice. Clin Immunol Immunopathol 1996;79:50-9.
10. Wicker LS, Appel MC, Dotta F, Pressey A, Miller BJ, DeLarato NH, et al. Autoimmune syndromes in the major histocompatibility complex (MHC) congenic strains of nonobese diabetic (NOD) mice: the NOD MHC is dominant for insulitis and cyclophosphamide-induced diabetes. J Exp Med 1992;176:67-77.
11. Li X, Golden J, Faustman D. Faulty MHC class II I-E expression is associated with autoimmunity in diverse strains of mice. Diabetes 1993;42:1166-72.
12. Wicker LS, Todd JA, Peterson LB. Genetic control of autoimmune diabetes in the NOD mouse. Annu Rev Immunol 1994;13:179-200.
13. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976;72:248-54.
14. Barrett AJ. A new assay for cathepsin B1 and other thiol proteinases. Anal Biochem 1972;47:280-93.
15. Henskins YMC, van der Velden U, Veerman EC, Nieun Amerongen AV. Protein, albumin and cystatin concentrations in saliva of healthy subjects and patients with gingivitis or periodontitis. J Periodont Res 1993;28:43-8.
16. Pugsley AP, Schnaitman CA. Factors affecting the electrophoretic mobility of the outer membrane proteins of Escherichia coli in polyacrylamide gels. Biochim Biophys Acta 1979;581:163-78.
17. Towbin H, Staehlin T, Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci U S A 1979;78:4350-4.
18. Robinson CP, Bounous DI, Alford CE, Nguyen K-HT, Nanni JM, Peck AB, et al. PSP expression in murine lacrimal glands and function as a bacterial binding protein in exocrine secretions. Am J Physiol 1997;272:G863-71.
19. Ball WD, Hand AR, Moreira JM, Iverson JM. Rabinovitch MR. The B-I immunoreactive proteins of the perinatal submandibular gland: similarity to the major parotid gland protein rPSP. Crit Rev Oral Biol Med 1993;4:517-9.
20. Mirels L, Ball WD. Neonatal rat submandibular gland proteins SMG-A and parotid secretory protein are alternatively regulated members of a salivary multigene family. J Biol Chem 1992; 267:2679-87.
21. Dilorio FC. Descriptive statistics. In: SASS Applications programming: a gentle introduction. Boston: PWS-Kent Publishing Co.; 1991. p. 87-121.
22. Yui MA, Muralidharan B, Moreno-Altamirano G, Chestnut K, Wakeland EK. Production of congenic mice strains carrying NOD-derived diabetogenic intervals: an approach for the genetic dissection of complex traits. Mamm Genome 1996;7:331-4.
23. Hayashi Y, Utsuyama M, Kurashima C, Hirokawa K. Spontaneous development of organ-specific autoimmune lesions in aged C57BL/6 mice. Clin Exp Immunol 1989;78:120-8.
24. Asamoto H, Oishi M, Okazawa Y, Tochino Y. Histology and immunologic changes in the thymus and other organs in NOD mice. In: Seiichiro T, Tochino Y, Noraka K, editors. Insulitis and type 1 diabetes. Tokyo: Academic Press; 1986. p. 61-71.
25. Robinson CP, Yamachika S, Alford CE, Cooper C, Pichardo EL, Shah N, et al. Elevated levels of cysteine protease activity in saliva and salivary glands of the NOD mouse model for Sjögren's syndrome. Proc Natl Acad Sci U S A 1997;94:5767-71.
26. Fraser A, Evan G. A license to kill. Cell 1996;85:781-4.
27. Kong L, Ogawa N, Nakabayashi T, Lui GT, D'Souza E, McGuff HS, et al. Fas and Fas ligand expression in the salivary glands of patients with primary Sjögren's syndrome. Arthritis Rheum 1997;40:87-97.
28. Yamamoto H, Sims NE, Macauley SP, Nguyen KH, Nakagawa Y, Humphreys-Beher MG. Alterations of the secretory response of NOD mice to muscarinic receptor stimulation. Clin Immunol Immunopathol 1996;78:245-55.
29. Hu Y, Purushotham KR, Wang P, Dawson R Jr, Humphreys-Beher MG. Down-regulation of beta-adrenergic receptors and signal transduction response in salivary glands of NOD mice. Am J Physiol 1994;266:G433-43.
30. null mice. J Exp Med 1996;184:2049-53.